NO20054002L - Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom - Google Patents
Behandlingsmiddel for diar±-predominant irritabel tarmsyndromInfo
- Publication number
- NO20054002L NO20054002L NO20054002A NO20054002A NO20054002L NO 20054002 L NO20054002 L NO 20054002L NO 20054002 A NO20054002 A NO 20054002A NO 20054002 A NO20054002 A NO 20054002A NO 20054002 L NO20054002 L NO 20054002L
- Authority
- NO
- Norway
- Prior art keywords
- diarrhea
- treatment
- bowel syndrome
- irritable bowel
- predominantly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2004/000896 WO2004066998A1 (ja) | 2003-01-31 | 2004-01-30 | 安定な経口用固形医薬組成物 |
| PCT/JP2004/006657 WO2005073220A1 (ja) | 2004-01-30 | 2004-05-12 | 下痢型過敏性腸症候群治療剤 |
| PCT/JP2005/001549 WO2005072730A1 (ja) | 2004-01-30 | 2005-01-27 | 下痢型過敏性腸症候群治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054002D0 NO20054002D0 (no) | 2005-08-29 |
| NO20054002L true NO20054002L (no) | 2005-10-26 |
Family
ID=34829390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054002A NO20054002L (no) | 2004-01-30 | 2005-08-29 | Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1559446B1 (pt) |
| AT (1) | ATE516061T1 (pt) |
| AU (1) | AU2005209112B2 (pt) |
| BR (1) | BRPI0503488A (pt) |
| CA (1) | CA2516433C (pt) |
| MX (1) | MXPA05009025A (pt) |
| NO (1) | NO20054002L (pt) |
| NZ (1) | NZ541656A (pt) |
| PL (1) | PL380448A1 (pt) |
| RU (1) | RU2314808C2 (pt) |
| WO (1) | WO2005072730A1 (pt) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0381422B1 (en) * | 1989-02-02 | 1996-10-23 | Yamanouchi Pharmaceutical Co. Ltd. | Tetrahydrobenzimidazole derivatives |
| GB9721139D0 (en) * | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
| WO1999064401A2 (en) * | 1998-06-12 | 1999-12-16 | Societe De Conseils De Recherches Et D'applications Scientifiques Sas | Imidazolyl derivatives and their use as somatostatin receptor ligands |
| AR028970A1 (es) * | 2000-07-26 | 2003-05-28 | Solvay Pharm Gmbh | USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE |
| US6566369B2 (en) * | 2000-07-26 | 2003-05-20 | Solvay Pharmaceuticals Gmbh | Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients |
-
2005
- 2005-01-27 NZ NZ541656A patent/NZ541656A/en not_active IP Right Cessation
- 2005-01-27 BR BRPI0503488-4A patent/BRPI0503488A/pt not_active IP Right Cessation
- 2005-01-27 WO PCT/JP2005/001549 patent/WO2005072730A1/ja not_active Ceased
- 2005-01-27 MX MXPA05009025A patent/MXPA05009025A/es active IP Right Grant
- 2005-01-27 PL PL380448A patent/PL380448A1/pl not_active Application Discontinuation
- 2005-01-27 RU RU2005127333/15A patent/RU2314808C2/ru not_active IP Right Cessation
- 2005-01-27 CA CA002516433A patent/CA2516433C/en not_active Expired - Fee Related
- 2005-01-27 AU AU2005209112A patent/AU2005209112B2/en not_active Ceased
- 2005-01-31 AT AT05001928T patent/ATE516061T1/de not_active IP Right Cessation
- 2005-01-31 EP EP05001928A patent/EP1559446B1/en not_active Expired - Lifetime
- 2005-08-29 NO NO20054002A patent/NO20054002L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0503488A (pt) | 2006-03-07 |
| EP1559446B1 (en) | 2011-07-13 |
| NZ541656A (en) | 2008-05-30 |
| MXPA05009025A (es) | 2006-04-27 |
| RU2314808C2 (ru) | 2008-01-20 |
| RU2005127333A (ru) | 2006-07-10 |
| CA2516433A1 (en) | 2005-08-11 |
| AU2005209112A1 (en) | 2005-08-11 |
| ATE516061T1 (de) | 2011-07-15 |
| WO2005072730A1 (ja) | 2005-08-11 |
| HK1090561A1 (zh) | 2006-12-29 |
| AU2005209112B2 (en) | 2007-07-05 |
| EP1559446A1 (en) | 2005-08-03 |
| NO20054002D0 (no) | 2005-08-29 |
| PL380448A1 (pl) | 2007-02-05 |
| CA2516433C (en) | 2009-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| MX2025001619A (es) | Inhibidor de pde4b y uso del mismo | |
| FI3782612T3 (fi) | Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi | |
| ES2916649T1 (es) | Composiciones y usos para el tratamiento de la esclerosis múltiple | |
| NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
| NO20062513L (no) | Sammensetninger og doseringsformer for forsterket absorpsjon av metformin | |
| CY1124914T1 (el) | Στερεες φαρμακευτικες συνθεσεις που περιεχουν αναστολεα ιντεγκρασης | |
| MY148108A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| ECSP077387A (es) | Composiciones que contienen piperacilina, tazobactam y un ácido aminocarboxílico en un diluyente de lactato de sodio | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| WO2021168483A3 (en) | Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors | |
| IL196425A0 (en) | Pharmaceutical compositions containing ibuprofen and famotidine | |
| NO20080244L (no) | Doseringsstyring for prasugrel | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| RU2003104798A (ru) | Содержащие циланзетрон лекарственные средства для лечения не страдающих запорами пациентов мужского пола с синдромом раздраженного кишечника (срк) | |
| ES2299738T3 (es) | Composicion farmaceutica que combina el tenatoprazol y un antagonista de los receptores h2 a la histamina. | |
| AR066667A1 (es) | Composiciones farmaceuticas que comrenden la combinacion de un agente derivado hidrogenado de lipstatina y un agente inhibidor de hmg coa reductasa | |
| SG146631A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
| BRPI0503488A (pt) | agente de tratamento para sìndrome de intestino irritável com diarréia predominante | |
| NO20044900L (no) | Progestagene doseringsenheter | |
| RU2023121182A (ru) | Применение 1-(2-(1н-имидазол-4-ил)этил)пиперидин-2,6-диона для лечения кашля, вызванного вирусными инфекциями | |
| MX2024001230A (es) | Anticoncepcion oral con progestageno solo. | |
| NZ782935A (en) | Treatments of hereditary angioedema | |
| AR051745A1 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyeccion | |
| RU2394581C3 (ru) | ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |